Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
39.4M
-
Shares change
-
+4.15M
-
Total reported value, excl. options
-
$385M
-
Value change
-
+$46.9M
-
Put/Call ratio
-
0.64
-
Number of buys
-
58
-
Number of sells
-
-31
-
Price
-
$9.76
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2018
100 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q1 2018.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.4M shares
of 114M outstanding shares and own 34.47% of the company stock.
Largest 10 shareholders include FMR LLC (7.92M shares), Redmile Group, LLC (6.66M shares), FRANKLIN RESOURCES INC (5.85M shares), BlackRock Inc. (2.9M shares), Casdin Capital, LLC (2.6M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), VANGUARD GROUP INC (1.82M shares), 683 Capital Management, LLC (994K shares), PRICE T ROWE ASSOCIATES INC /MD/ (963K shares), and Artal Group S.A. (850K shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.